Options Edge: Citigroup, Medtronic, Delta Air Lines, and Tiffany & Co.

The banking behemoth sold its Diners Club credit card business to a Canadian peer

by Elizabeth Harrow (eharrow@sir-inc.com) 11/24/2009 9:26 AM


Today's column includes yet another asset sale for Citigroup Inc. (C), a rosy forecast from Medtronic, Inc. (MDT), a price-target cut for Delta Air Lines, Inc. (DAL), and some positive pre-earnings sentiment for Tiffany & Co. (TIF). Each day, Options Edge focuses on the hot stocks in the news and gives you a unique insight into each stock's sentiment backdrop. Our time-tested contrarian approach centers on options, and gives you the trading tools to approach the day with a much-needed edge over the investing herd.

Citigroup Inc.

Citigroup Inc. (C: View sentiment for Csentiment, chart, options) has agreed to sell its Diners Club North America credit card business to BMO Financial Group, the parent company of Bank of Montreal (BMO), as it continues to shed non-core assets and rebuild its primary banking business. The terms of the deal haven't been disclosed, but BMO now has exclusive rights to issue Diners Club cards in the U.S. and Canada. The transaction is expected to close by the end of March, subject to regulatory approval.

C price chartCitigroup said the sale will reduce its assets in Citi Holdings by roughly $1 billion, and it's not expected to have a material impact on the bank's net income or capital ratios. However, BMO will approximately double its corporate card business, since the Diners Club card is favored by business travelers.

C shares are flat in pre-market trading as investors digest the news. The stock is currently pinned between support at its 20-week moving average and resistance from its 10-week moving average. These two trendlines have sandwiched the security since late October.

During the short term, the equity's range-bound price trend could be exacerbated by heavy out-of-the-money call open interest. The newly front-month December 5 strike is home to peak call open interest of 670,201 contracts, which could exert options-related resistance as expiration draws closer.

Medtronic, Inc.

Medtronic, Inc. (MDT: View sentiment for MDTsentiment, chart, options) stepped into the earnings spotlight this morning, with the medical device maker reporting a fiscal second-quarter profit of $868 million, or 78 cents per share, up 59% from the year-ago period. Excluding items, MDT raked in 77 cents per share, exceeding analysts' consensus expectations for a profit of 74 cents per share. Revenue for the period arrived at $3.84 billion, up 8% from the same quarter last year, and besting Wall Street's forecast for $3.75 billion.

Looking ahead, MDT raised its fiscal 2010 earnings outlook from $3.10 to $3.20 per share to a new range between $3.17 and $3.22 per share. Edward Jones analyst Aaron Vaughn seemed impressed by the results, telling Reuters, "Clearly, they have confidence in the business going forward."

MDT is up 5.7% ahead of the open, catching a lift from support at its 10-day moving average. Today's post-earnings pop could help the stock establish a firm foothold atop the troublesome $40 level, which has capped the shares' progress since early November.

Prior to the earnings report, option players loaded up on bullish positions. During the past 10 days, traders on the International Securities Exchange (ISE) bought to open 2.54 calls for every put on MDT. This ratio ranks in the 79th annual percentile, revealing a stronger-than-usual bias toward calls over puts. However, with short interest rising 8.2% during the most recent reporting period, some of these calls might have been picked up as hedges.

Today's Most Popular Stories




Featured Companies





Receive FREE access to Schaeffer’s
Sentiment Spring 2009
premier online options magazine!



Partner Center

tribal fussion